Accessibility Menu
 
Ardelyx logo

Ardelyx

(NASDAQ) ARDX

Current Price$5.55
Market Cap$1.34B
Since IPO (2014)-61%
5 Year-12%
1 Year+7%
1 Month-16%

Ardelyx Financials at a Glance

Market Cap

$1.34B

Revenue (TTM)

$407.32M

Net Income (TTM)

$61.60M

EPS (TTM)

$-0.26

P/E Ratio

-21.27

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Price

$5.55

Volume

68,150

Open

$5.42

Previous Close

$5.55

Daily Range

$5.35 - $5.58

52-Week Range

$3.21 - $8.40

ARDX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ardelyx

Industry

Biotechnology

Employees

489

CEO

Mike Raab

Headquarters

Waltham, MA 02451, US

ARDX Financials

Key Financial Metrics (TTM)

Gross Margin

90%

Operating Margin

-10%

Net Income Margin

-15%

Return on Equity

-36%

Return on Capital

-10%

Return on Assets

-12%

Earnings Yield

-4.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.34B

Shares Outstanding

245.25M

Volume

68.15K

Short Interest

0.00%

Avg. Volume

4.70M

Financials (TTM)

Gross Profit

$367.78M

Operating Income

$40.98M

EBITDA

$29.17M

Operating Cash Flow

$42.48M

Capital Expenditure

$1.49M

Free Cash Flow

$43.98M

Cash & ST Invst.

$264.69M

Total Debt

$211.59M

Ardelyx Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$125.22M

+7.8%

Gross Profit

$111.70M

+14.1%

Gross Margin

89.21%

N/A

Market Cap

$1.34B

N/A

Market Cap/Employee

$3.40M

N/A

Employees

395

N/A

Net Income

$407.00K

-108.8%

EBITDA

$10.29M

-6.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$53.09M

-45.1%

Accounts Receivable

$71.85M

+24.5%

Inventory

$17.73M

-16.2%

Long Term Debt

$210.12M

+38.3%

Short Term Debt

$1.48M

-5.3%

Return on Assets

-12.25%

N/A

Return on Invested Capital

-9.89%

N/A

Free Cash Flow

$20.59M

+123.4%

Operating Cash Flow

$20.95M

+113.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NTLAIntellia Therapeutics, Inc.
$11.65-5.82%
MAZEMaze Therapeutics, Inc.
$29.01-4.51%
TRVITrevi Therapeutics, Inc.
$11.19-1.24%
WVEWave Life Sciences Ltd.
$6.62+4.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.52+0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$37.89-0.02%
INTCIntel
$41.19-0.04%
QQQInvesco QQQ Trust
$558.28-0.01%

Questions About ARDX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.